Cart
sales@molnova.com
SantacruzaMate A
CAS No. 1477949-42-0
SantacruzaMate A( CAY10683 | CAY-10683 | CAY 10683 | Santacruzamate A )
Catalog No. M18042 CAS No. 1477949-42-0
Santacruzamate A (CAY10683) is a potent and selective HDAC inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 43 | In Stock |
|
| 10MG | 50 | In Stock |
|
| 25MG | 107 | In Stock |
|
| 50MG | 193 | In Stock |
|
| 100MG | 289 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSantacruzaMate A
-
NoteResearch use only, not for human use.
-
Brief DescriptionSantacruzamate A (CAY10683) is a potent and selective HDAC inhibitor.
-
DescriptionCAY10683, also known as Santacruzamate A, is a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp. CAY10683 inhibits HDAC2 and HDAC6 with IC50 values of 0.119 and 434 nM, respectively.
-
In Vitro——
-
In Vivo——
-
SynonymsCAY10683 | CAY-10683 | CAY 10683 | Santacruzamate A
-
PathwayOthers
-
TargetOther Targets
-
RecptorHDAC2| HDAC4| HDAC6
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number1477949-42-0
-
Formula Weight278.35
-
Molecular FormulaC15H22N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL; 359.26 mM
-
SMILESCCOC(=O)NCCCC(=O)NCCc1ccccc1
-
Chemical Nameethyl (4-oxo-4-(phenethylamino)butyl)carbamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pavlik CM, et al. J Nat Prod. 2013, 76(11), 2026-2033.
molnova catalog
related products
-
Misonidazole
Misonidazole as a novel GPX inhibitors to cause oxidative stress in chemotherapy-resistant tumors.
-
Trans-caffeic acid
Trans-caffeic acid stearyl ester is posited to inhibit melanogenesis signaling while suppressing cAMP levels and, subsequently, MC1R, MITF, tyrosinase, TRP-2 and TRP-1 down-regulation, resulting in the suppression of tyrosinase activity, DOPA oxidase activity and melanin synthesis.
-
UCM-13207
UCM-13207 is a specific ICMT inhibitor that improves progeria.
